WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'7201 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 7'7621 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 6'340  6'297  6'256  6'218  6'183  5'959  5'344  4'661 
Births 128  128  127  127  127  146  170  176 
Surviving infants 125  125  125  125  125  143  163  161 
Pop. less than 5 years 635  639  636  621  617  777  791  784 
Pop. less than 15 years 1'900  1'934  1'967  1'995  2'029  2'282  2'227  2'107 
Female 15-49 years 1'796  1'770  1'744  1'720  1'695  1'499  1'287  1'058 

Number of reported case

(Click for retrospective incidence data for El Salvador)
Diphtheria
Japanese encephalitis
Measles 2'315 
Mumps 274  351  632  369  126  1'170 
Pertussis 37  1'003 
Polio* 55 
Rubella 298 
Rubella (CRS)
Tetanus (neonatal) 25  61 
Tetanus (total) 10  13  98 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for El Salvador)
Vaccine year result method % card seen                                                
BCG          90  90  91  89  88  99  75  56 
DTP1 1984  88  DHS   75  91  92  90  90  90  87 
DTP3          92  92  89  89  91  99  80  44 
HepB_BD          87  99* 
HepB3          92  92  89  89  91  99 
Hib3          92  92  89  89  91 
JapEnc         
MCV          94  93  89  92  91  97  98  45 
MCV2          85  95  81  78  82 
PCV1          91  93  77 
PCV3          92  94  98  69 
Pol3          92  93  90  89  89  98  80  42 
Rota1          92  93  90  90  77 
Rota_last          92  93  90  90  62 
Rubella1          94  93  89  91  95 
TT2plus          86  70  68  90  26 
PAB         
VAD1          57  10  42 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for El Salvador)
BCG 90  90  91  89  88  99  75  56 
DTP1 97  92  90  90  97  99  93  69 
DTP3 92  92  89  89  91  99  80  44 
HepB3 92  92  89  89  91  99 
HepB_BD
Hib3 92  92  89  89  91 
MCV 94  93  89  92  91  97  98  45 
MCV2 85  95  81  78  82 
PAB 90  90  88  88  87  83  37  23 
PCV3 92  94  98  69 
Pol3 92  93  90  89  91  98  80  42 
Rota_last 92  93  90  90  62 

Number of districts in the country 262  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 63
From 80 to 89% 19
From 50 to 79% 16
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 15-18 months; 4 years; risk groups
DTwP 4 years; Yes
DTwPHibHep 2, 4, 6, 15 months; Yes
HepB HCW and risk groups
IPV 2, 4, 12 months; Yes HIV patients
Influenza 6-59 months; >60 years; Yes and risk groups and PW
MMR 12 months; 4 years; Yes
OPV 2, 4, 6, 15-18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 60 years; HCW and risk groups
Rotavirus 2, 4 months; Yes
Td every 10 years
VitaminA < 5 years; Yes
YF Travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2009 - 2014  2009-2014  2009-2014  2009-2013    2004-2009  2004-2009 
Nº of districts with microplans that include activities to raise immunization coverage number 262  262  262  262  262  262  262 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 262  262      262  262  262 
Nº districts with DTP3 coverage >=80% number 216  221  202  185  224  224  44 
% of districts with DTP3 coverage >=80% From 0 to 100% 82  84      85  85  17 
Nº districts with measles (MCV1) coverage >=95% number 159  150  119  101  155  138   
% of districts with MCV1 coverage >=95% From 0 to 100% 61  57      59  53   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100    100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.